PDG3 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE (17-OHPC)) UTILIZATION, ADHERENCE, AND OUTCOMES IN WOMEN WITH A HIGH-RISK PREGNANCY
May 1, 2020, 00:00
10.1016/j.jval.2020.04.294
https://www.valueinhealthjournal.com/article/S1098-3015(20)30482-4/fulltext
Title :
PDG3 EVALUATION OF PROGESTERONE (17-ALPHA HYDROXYPROGESTERONE CAPROATE (17-OHPC)) UTILIZATION, ADHERENCE, AND OUTCOMES IN WOMEN WITH A HIGH-RISK PREGNANCY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30482-4&doi=10.1016/j.jval.2020.04.294
First page :
Section Title :
Open access? :
No
Section Order :
10154